Peptide Antibiotics Market Size, Share, and COVID-19 Impact Analysis, By Product (Ribosomal Synthesized Peptide Antibiotics and Non-Ribosomal Synthesized Peptide Antibiotics), By Indication (Skin Infections, Pulmonary Infections, Hospital Acquired Infections, and Others), Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2026-2034